Last price paid | 0.89 | |
Change | +4.71% [ +0.04 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 23.08.2024 17:20 |
Fixing | n.a. |
Settlement date | 08.05.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +57.02% |
Year to date (YTD) | n.a. |
1 month | +1.14% |
3 months | -13.59% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.57 |
Underlying price on issue | 853.80 |
Premium | 0.03% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1338498137 |
Symbol | INOEPZ |
Security | 133849813 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Novo Nordisk -B-, DK0062498333 |
Underlying ISIN | DK0062498333 |
Funding level | 761.251700 |
Stop-loss level | 790.391700 |
Distance to stop-loss level | 13.33% |
Long/Short type | Long |
Subscription ratio | 25.00 |
Issuer | Zuercher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 06.05.2024 |
Premium | 2.76% |
Premium p.a. | n.a. |
Leverage | 5.18 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 150.748300 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Swiss Re | 117.85 |
SONOVA HLDG N | 298.20 |
KUEHNE & NAGEL | 262.10 |
GEBERIT N | 533.60 |
Holcim | 81.42 |
Name | Price |
---|---|
Lonza Group | 559.40 |
LOGITECH INT. | 77.94 |
NOVARTIS N | 100.40 |
ROCHE GS | 283.20 |
Nestlé SA | 89.54 |